Free Trial

Metis Global Partners LLC Cuts Position in LyondellBasell Industries (NYSE:LYB)

LyondellBasell Industries logo with Basic Materials background

Metis Global Partners LLC trimmed its stake in LyondellBasell Industries (NYSE:LYB - Free Report) by 42.9% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 8,277 shares of the specialty chemicals company's stock after selling 6,221 shares during the quarter. Metis Global Partners LLC's holdings in LyondellBasell Industries were worth $794,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. CVA Family Office LLC lifted its holdings in shares of LyondellBasell Industries by 155.9% during the third quarter. CVA Family Office LLC now owns 261 shares of the specialty chemicals company's stock valued at $25,000 after purchasing an additional 159 shares in the last quarter. Beacon Capital Management LLC purchased a new stake in LyondellBasell Industries during the first quarter valued at $28,000. Blue Trust Inc. increased its position in LyondellBasell Industries by 311.0% during the second quarter. Blue Trust Inc. now owns 300 shares of the specialty chemicals company's stock valued at $31,000 after acquiring an additional 227 shares during the last quarter. Matrix Trust Co purchased a new stake in LyondellBasell Industries in the third quarter worth about $30,000. Finally, Ashton Thomas Securities LLC purchased a new stake in LyondellBasell Industries in the third quarter worth about $31,000. 71.20% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have commented on LYB. Piper Sandler reduced their price target on LyondellBasell Industries from $117.00 to $112.00 and set an "overweight" rating for the company in a research report on Friday, November 8th. Evercore ISI upgraded LyondellBasell Industries to a "hold" rating in a research report on Monday, August 5th. Mizuho reduced their price target on LyondellBasell Industries from $101.00 to $97.00 and set a "neutral" rating for the company in a research report on Monday, November 4th. StockNews.com upgraded LyondellBasell Industries from a "hold" rating to a "buy" rating in a research report on Thursday. Finally, Royal Bank of Canada cut their target price on LyondellBasell Industries from $110.00 to $104.00 and set an "outperform" rating for the company in a research report on Monday, November 4th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $101.70.

View Our Latest Stock Report on LYB

LyondellBasell Industries Trading Up 0.6 %

Shares of NYSE:LYB traded up $0.50 during trading on Monday, hitting $83.15. The company had a trading volume of 879,537 shares, compared to its average volume of 1,866,089. The stock has a market cap of $27.00 billion, a price-to-earnings ratio of 12.58, a price-to-earnings-growth ratio of 2.31 and a beta of 1.08. LyondellBasell Industries has a one year low of $82.20 and a one year high of $107.02. The company has a fifty day simple moving average of $91.13 and a two-hundred day simple moving average of $94.87. The company has a debt-to-equity ratio of 0.81, a current ratio of 2.13 and a quick ratio of 1.25.

LyondellBasell Industries (NYSE:LYB - Get Free Report) last issued its quarterly earnings results on Friday, November 1st. The specialty chemicals company reported $1.88 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.98 by ($0.10). LyondellBasell Industries had a return on equity of 17.05% and a net margin of 5.29%. The business had revenue of $10.33 billion for the quarter, compared to the consensus estimate of $10.60 billion. During the same period in the prior year, the business posted $2.46 earnings per share. LyondellBasell Industries's revenue was down 2.8% on a year-over-year basis. As a group, equities analysts forecast that LyondellBasell Industries will post 7.09 earnings per share for the current year.

About LyondellBasell Industries

(Free Report)

LyondellBasell Industries N.V. operates as a chemical company in the United States, Germany, Mexico, Italy, Poland, France, Japan, China, the Netherlands, and internationally. The company operates in six segments: Olefins and PolyolefinsAmericas; Olefins and PolyolefinsEurope, Asia, International; Intermediates and Derivatives; Advanced Polymer Solutions; Refining; and Technology.

Recommended Stories

Institutional Ownership by Quarter for LyondellBasell Industries (NYSE:LYB)

Should you invest $1,000 in LyondellBasell Industries right now?

Before you consider LyondellBasell Industries, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LyondellBasell Industries wasn't on the list.

While LyondellBasell Industries currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines